Debunking the myth of 'Blue Mondays': No evidence of affect drop after taking clinical MDMA.

The results support the overall safety and tolerability of clinically administered MDMA and, importantly, suggest that the 'come downs' previously associated with the substance may be explained by confounds in research relating to the illicit sourcing of the drug and specific environmental setting for recreational consumption.